Mia M. Gaudet, PhD

Strategic Director, Breast and Gynecologic Cancer Research

Mia M. Gaudet, PhD, MSPH is a cancer epidemiologist and strategic director for gynecologic and breast cancers at the American Cancer Society. Gaudet’s research focuses on lifestyle, hormonal, and genetic factors associated with risk of and survival from cancers of the breast, ovary, and endometrium. She is leading the effort to collect tissues from the breast cancer cases in the Cancer Prevention Study-II and from the breast and ovarian cancer cases in the Cancer Prevention Study-3. As an expert in the field of breast cancer epidemiology, Gaudet was invited to be an author of the chapter on Breast Cancer in the 4th edition of Cancer Epidemiology and Prevention (Schottenfeld and Fraumeni, eds), a premier reference text in cancer epidemiology. In addition, her research has contributed significantly to the scientific evidence on the role of cigarette smoking and breast cancer etiology (e.g., Journal of the National Cancer Institute, 2014). She has evaluated the role of genetic variation in relationship to cancer risk using candidate and genome-wide approaches in high risk and general populations. Current areas of research include studies of factors associated with breast cancer survival in women diagnosed with breast cancer.

Prior to joining the American Cancer Society in 2010, Gaudet held faculty positions in the Department of Epidemiology and Population Health at the Albert Einstein College of Medicine and in Department of Epidemiology and Biostatistics at the Memorial Sloan-Kettering Cancer Center in New York City.

Gaudet has authored more than 120 peer-reviewed publications, as well as numerous invited commentaries, book chapters, and reviews.

Education:
• Postdoctoral Fellow, Division of Cancer Epidemiology and Genetics, National Cancer Institute, 2007
• PhD, Epidemiology, University of North Carolina at Chapel Hill, 2005
• MSPH, Epidemiology, University of North Carolina at Chapel Hill, 2001